Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 178325
Corporate User License Price USD 3200
Corporate User License Price INR 228256
Request a Quote

Report Title

Asia-Pacific Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Quote Request for License Type
License Type Price  
Single User License USD 2500
Enterprise Wide License USD 3200
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Asia-Pacific Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Asia-Pacific Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Asia-Pacific Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025



Executive Summary

Asia-Pacific bio-implants market is expected to reach USD 57,623.77 million by 2025, from USD 31,405.05 million in 2017 growing at a CAGR of 8.0% in the forecast period 2018 to 2025.

The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.

The key market players for Asia-Pacific Bio-Implants Market are listed below:

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg

The market is further segmented into:

Product Type

Type

Material

Mode of Administration

End-user

The Asia-Pacific bio-implants market is segmented based on product type into orthopedics & trauma, pacing devices, stents & related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others. In 2018, orthopedics & trauma segment is expected to dominate the Asia-Pacific bio-implants market with 25.6% market share and is expected to reach USD 15,190.83 million by 2025, growing at the highest CAGR of 8.7% in the forecast period 2018 to 2025.

The Asia-Pacific bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, allograft segment is expected to dominate the Asia-pacific bio-implants market with 43.0% market share and are expected to reach USD 25,261.15 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.

The Asia-Pacific bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, biomaterial metal is expected to dominate the Asia-pacific bio-implants market with 31.9% market share and is expected to reach USD 18,445.19 million by 2025, growing at a CAGR of 8.1% in the forecast period 2018 to 2025. However, alloy is expected to grow at the highest CAGR of 8.4% in the forecast period, to reach USD 15,727.91 million by 2025 from USD 8,287.20 million in 2017 in the forecast period 2018 to 2025.

The Asia-Pacific bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical is expected to dominate the Asia-pacific bio-implants market with 60.7% market share and is expected to reach USD 34,271.71 million by 2025, growing at the highest CAGR of 7.7% in the forecast period 2018 to 2025. However, non-surgical is expected to grow at the highest CAGR of 8.5% in the forecast period, to reach USD 23,352.06 million by 2025 from USD 12,287.92 million in 2017 in the forecast period 2018 to 2025.

The Asia-Pacific bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, hospitals is expected to dominate the Asia-pacific bio-implants market with 46.3% market share and is expected to reach USD 27,038.31 million by 2025, growing at the highest CAGR of 8.2% in the forecast period 2018 to 2025.

.Based on geography, the Asia-Pacific bio-implants market is segmented into geographical regions, such as,

China,

Japan,

India,

South Korea,

Australia,

Thailand,

Malaysia,

Singapore,

Indonesia,

Philippines

Rest of Asia-Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table Of Contents

1. Introduction 68

1.1. Objectives Of The Study 68

1.2. Market Definition 68

1.3. Overview Of Asia-Pacific Bio-Implants Market 68

1.4. Currency And Pricing 70

1.5. Limitation 70

1.6. Markets Covered 71

2. Market Segmentation 75

2.1. Markets Covered 75

2.2. Geographic Scope 76

2.3. Years Considered For The Study 77

2.4. Currency And Pricing 77

2.5. Research Methodology 78

2.6. Primary Interviews With Key Opinion Leaders 81

2.7. Secondary Sources 82

2.8. Assumptions 82

3. Market Overview 83

3.1. Drivers 85

3.1.1. Rising Number Of Aging And Geriatric Population 85

3.1.2. Changing Lifestyle Problems 85

3.1.3. Rising Incidence Of Chronic Diseases 86

3.1.4. Increasing Awareness About Cosmetic Implants 87

3.1.5. Technological Advancement In Implants 88

3.1.6. Rising Demand For Non-Surgical Bio-Implants 88

3.2. Restraints 89

3.2.1. High Cost Of Implants 89

3.2.2. Regulatory Scenario 89

3.2.3. Unfavourable Reimbursement Policies 90

3.3. Opportunities 91

3.3.1. Emerging Inclination For Mis Surgeries 91

3.3.2. Growing Number Of Diagnostic Centers And Clinics 92

3.3.3. Emerging Countries 92

3.3.4. Rising Medical Tourism 93

3.4. Challenges 94

3.4.1. Side-Effects Of Various Cosmetic Surgery 94

3.4.2. Lack Of Trained Professionals 94

4. Executive Summary 95

5. Premium Insights 99

6. Asia-Pacific Bio-Implants Market, By Product Type 101

6.1. Overview 102

6.2. Orthopedics & Trauma 104

6.2.1. Reconstructive Joint Replacements 106

6.2.1.1. Knee Replacement Implants 106

6.2.1.2. Hip Replacement Implants 106

6.2.1.3. Extremities 107

6.2.2. Orthobiologics 109

6.2.2.1. Hyaluronic Acid 109

6.2.2.2. Bone Substitutes 110

6.2.2.3. Bone Growth Factors 110

6.2.2.4. Tissue Implants 110

6.2.2.5. Bone Cement 110

6.2.3. Trauma Implants 111

6.2.3.1. Internal Trauma Fixation Devices 111

6.2.3.2. Craniomaxillofacial Fixation Devices 111

6.2.3.3. Implantable Trauma Stimulators 112

6.2.4. Sports Medicine 112

6.3. Pacing Devices 112

6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 113

6.3.2. Implantable Cardioverter Defibrillators (Icd) 114

6.3.3. Implantable Cardiac Pacemakers (Icp) 114

6.3.3.1. Single Chambered 115

6.3.3.2. Dual Chambered 115

6.3.3.3. Multiple Chambered 115

6.3.4. Pacing Accessories 115

6.3.4.1. Pacing Leads 116

6.3.4.2. Pacing Batteries 116

6.4. Stents & Related Implants 116

6.4.1. Coronary Stents 118

6.4.1.1. Drug-Eluting Stents 118

6.4.1.2. Bare-Metal Coronary Stents 119

6.4.1.3. Bioabsorbable Stents 119

6.4.2. Peripheral Stents 119

6.4.2.1. Endovascular Stent-Grafts 120

6.4.2.2. Renal & Related Stents 120

6.4.2.3. Femoral & Related Stents 120

6.4.2.4. Carotid Stents 120

6.4.3. Stent-Related Implants 121

6.4.3.1. Synthetic Grafts 121

6.4.3.2. Vascular Grafts 122

6.4.3.3. Peripheral Grafts 122

6.4.3.4. Vena Cava Filters 122

?

6.5. Spinal Implants 123

6.5.1. Thoracolumbar Implants 124

6.5.2. Intervertebral Spacers 124

6.5.3. Machined Allograft Spacers 125

6.5.4. Cervical Implants 125

6.5.5. Motion Preservation Implants 125

6.5.6. Implantable Spinal Stimulators 125

6.6. Ophthalmic Implants 125

6.6.1. Intraocular Lens 127

6.6.2. Glaucoma & Other Lenses 127

6.7. Structural Cardiac Implants 127

6.7.1. Heart Valves & Accessories 129

6.7.2. Tissue Heart Valves 129

6.7.3. Mechanical Heart Valves 129

6.7.4. Heart Valve Repair Devices 129

6.7.5. Ventricular Assist Device (Vad) 129

6.7.6. Implantable Heart Monitors 130

6.7.7. Insertable Loop Recorders (Ilrs) 130

6.7.8. Implantable Hemodynamic Monitors (Ihm) 130

6.8. Dental Implants 131

6.8.1. Plate Form Dental Implants 132

6.8.2. Root Form Dental Implants 132

6.9. Neurostimulators Implants 133

6.9.1. Cortical Stimulators 134

6.9.2. Deep Brain Stimulators 134

6.9.3. Sacral Nerve Stimulators 134

6.9.4. Spinal Cord Stimulators 135

6.9.5. Vagus Nerve Stimulators 135

?

6.10. Prosthetic Implants 135

6.10.1. Osseointegration 136

6.10.2. Titanium-Based Prosthetic Implants 136

6.11. Others 137

6.11.1. Gynecological Devices 138

6.11.2. Drug Implants 138

6.11.3. Cosmetic Implants 139

6.11.4. Gastroenterological Implants 139

6.11.5. Urological Implants 139

6.11.6. Skin & Wound Care 139

6.11.7. Otolaryngeal Implants 139

7. Asia-Pacific Bio-Implants Market, By Type 140

7.1. Overview 141

7.2. Allograft 143

7.3. Autograft 144

7.4. Xenograft 145

7.5. Synthetic 146

7.6. Others 147

8. Asia-Pacific Bio-Implants Market, By Material 148

8.1. Overview 149

8.2. Biomaterial Metal 151

8.2.1. Titanium 152

8.2.2. Gold 152

8.2.3. Silver 152

8.2.4. Platinum 153

8.3. Alloy 153

?

8.4. Polymer 154

8.4.1. Natural Polymers 155

8.4.2. Synthetic Polymers 155

8.5. Ceramics 156

8.6. Acrylic Hydrogel 157

9. Asia-Pacific Bio-Implants Market, Mode Of Administration 158

9.1. Overview 159

9.2. Surgical 161

9.3. Non-Surgical 162

9.3.1. Injectable Fillers/Biomaterials 163

9.3.2. Osteogenic Injectable Bone Substitutes 163

9.3.3. Viscosupplementation 164

9.3.4. Viscoaugmentation 164

10. Asia-Pacific Bio-Implants Market, By End-User 165

10.1. Overview 166

10.2. Clinics 168

10.3. Hospitals 169

10.4. Ambulatory Surgical Centers 170

10.5. Others 171

11. Asia-Pacific Bio-Implants Market, By Geography 172

11.1. Asia-Pacific 173

11.1.1. Japan 195

11.1.2. China 210

11.1.3. India 225

11.1.4. South Korea 240

11.1.5. Australia 255

11.1.6. Singapore 270

11.1.7. Thailand 285

11.1.8. Malaysia 300

11.1.9. Indonesia 315

11.1.10. Philippines 330

11.1.11. Rest Of Asia-Pacific 345

12. Asia-Pacific Bio-Implants Market, Company Landscape 346

12.1. Company Share Analysis: Asia Pacific 346

13. Company Profiles 347

13.1. Medtronic 347

13.1.1. Company Overview 347

13.1.2. Revenue Analysis 348

13.1.3. Product Portfolio 349

13.1.4. Recent Developments 350

13.2. Johnson & Johnson Services, Inc. 351

13.2.1. Company Overview 351

13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis 351

13.2.3. Product Portfolio 352

13.2.4. Recent Developments 352

13.3. Edward Lifesciences Corporation 353

13.3.1. Company Overview 353

13.3.2. Edward Lifesciences Corporation :Revenue Analysis 353

13.3.3. Product Portfolio 354

13.3.4. Recent Developments 354

13.4. Boston Scientific Corporation 355

13.4.1. Company Overview 355

13.4.2. Boston Scientific Corporation: Revenue Analysis 355

13.4.3. Product Portfolio 356

13.4.4. Recent Developments 356

?

13.5. Integra Lifesciences Corporation 357

13.5.1. Company Overview 357

13.5.2. Integra Lifesciences Corporation :Revenue Analysis 357

13.5.3. Product Portfolio 358

13.5.4. Recent Developments 358

13.6. Abbott 359

13.6.1. Company Overview 359

13.6.2. Abbott :Revenue Analysis 359

13.6.3. Product Portfolio 360

13.6.4. Recent Developments 360

13.7. C. R. Bard, Inc. 361

13.7.1. Company Overview 361

13.7.2. C. R. Bard, Inc.:Revenue Analysis 361

13.7.3. Product Portfolio 362

13.7.4. Recent Developments 362

13.8. Zimmer Biomet 363

13.8.1. Company Overview 363

13.8.2. Zimmer Biomet :Revenue Analysis 363

13.8.3. Product Portfolio 364

13.8.4. Recent Developments 364

13.9. Biotronik Se & Co. Kg 365

13.9.1. Company Overview 365

13.9.2. Biotronik Se & Co. Kg :Company Snapshot 365

13.9.3. Product Portfolio 366

13.9.4. Recent Developments 366

13.10. Lifenet Health, Inc. 367

13.10.1. Company Overview 367

13.10.2. Lifenet Health, Inc.:Company Snapshot 367

13.10.3. Product Portfolio 368

13.10.4. Recent Developments 368

13.11. Integrated Orbital Implants 369

13.11.1. Company Overview 369

13.11.2. Integrated Orbital Implants :Company Snapshot 369

13.11.3. Product Portfolio 370

13.11.4. Recent Developments 370

13.12. Smith & Nephew 371

13.12.1. Company Overview 371

13.12.2. Smith & Nephew :Revenue Analysis 371

13.12.3. Product Portfolio 372

13.12.4. Recent Developments 373

13.13. Stryker 374

13.13.1. Company Overview 374

13.13.2. Stryker :Revenue Analysis 374

13.13.3. Product Portfolio 375

13.13.4. Recent Developments 375

13.14. W. L. Gore & Associates, Inc 376

13.14.1. Company Overview 376

13.14.2. W. L. Gore & Associates, Inc :Company Snapshot 376

13.14.3. Product Portfolio 377

13.14.4. Recent Developments 377

13.15. Valeant Pharmaceuticals International Inc. 378

13.15.1. Company Overview 378

13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis 378

13.15.3. Product Portfolio 379

13.15.4. Recent Developments 379

?

13.16. Somnomed 380

13.16.1. Company Overview 380

13.16.2. Somnomed :Revenue Analysis 380

13.16.3. Product Portfolio 381

13.16.4. Recent Developments 381

13.17. Wright Medical Group N.V. 382

13.17.1. Company Overview 382

13.17.2. Wright Medical Group N.V.:Revenue Analysis 382

13.17.3. Product Portfolio 383

13.17.4. Recent Developments 383

13.18. Livanova Plc 384

13.18.1. Company Overview 384

13.18.2. Livanova Plc :Revenue Analysis 384

13.18.3. Product Portfolio 385

13.18.4. Recent Developments 385

13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 386

13.19.1. Company Overview 386

13.19.2. St. Jude Medical, Inc.:Company Snapshot 386

13.19.3. Product Portfolio 387

13.19.4. Recent Developments 387

13.20. Mimedx Group, Inc. 388

13.20.1. Company Overview 388

13.20.2. Mimedx Group, Inc.:Revenue Analysis 388

13.20.3. Product Portfolio 389

13.20.4. Recent Developments 389

?

13.21. Cook Group 390

13.21.1. Company Overview 390

13.21.2. Cook Group :Company Snapshot 390

13.21.3. Product Portfolio 390

13.21.4. Recent Developments 390

14. Related Reports 391

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Figures List

Figure 1 Asia-Pacific Bio-Implants Market : Segmentation 44

Figure 2 Asia-Pacific Bio-Implants Market: Data Triangulation 47

Figure 3 Asia-Pacific Bio-Implants Market: Research Snapshot 48

Figure 4 Asia-Pacific Bio-Implants Market : Bottom Up Approach 49

Figure 5 Asia-Pacific Bio-Implants Market : Top Down Approach 49

Figure 6 Asia-Pacific Bio-Implants Market: Interview Demographics 50

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Asia-Pacific Bio-Implants Market 53

Figure 8 Number Of Cosmetic Surgeries Performed In 2000, 2015, And 2016 In U.S. 56

Figure 9 Asia-Pacific Bio-Implants Market: Segmentation 66

Figure 10 North America Is Expected To Dominate The Market For Bio-Implants And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 67

Figure 11 Rising Number Of Aging And Geriatric Population, And Increased Incidences Of Chronic Diseases Are Expected To Drive The Market For Bio-Implants In The Forecast Period 2018 To 2025 68

Figure 12 Orthopedics & Trauma Segment Is Expected To Account For The Largest Share Of The Asia-Pacific Bio-Implants Market In 2018 & 2025 69

Figure 13 Asia-Pacific Bio-Implants Market: By Product Type, 2017 71

Figure 14 Asia-Pacific Bio-Implants Market: By Type, 2017 110

Figure 15 Asia-Pacific Bio-Implants Market: By Material, 2017 118

Figure 16 Asia-Pacific Bio-Implants Market: By Mode Of Administration, 2017 128

Figure 17 Asia-Pacific Bio-Implants Market: By End-User, 2017 135

Figure 18 Asia-Pacific Bio-Implants Market: Snapshot (2017) 143

Figure 19 Asia-Pacific Bio-Implants Market: By Country (2017) 144

Figure 20 Asia-Pacific Bio-Implants Market: By Country (2018 & 2025) 145

Figure 21 Asia-Pacific Bio-Implants Market, By Country (2017 & 2025) 146

Figure 22 Asia-Pacific Bio-Implants Market, By Product Type (2018 & 2025) 147

Figure 23 Asia Pacific Bio-Implants Market: Company Share 2017 (%) 315

The Table Is Too Lengthy To Be Pasted

Abbott Laboratories

Medtronic

Boston Scientific Corporation

Bio-Rad Laboratories, Inc.

Somnomed Limited

Johnson & Johnson Services, Inc.

Edwards Lifesciences Corporation

F. Hoffmann-La Roche AG

C.R. Bard, Inc.

Mimedx Group, Inc.

Biotronik Se & Co.Kg


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person